Suppr超能文献

基于网络药理学的黄芪治疗糖尿病肾病作用机制研究

A Study on the Mechanism of Milkvetch Root in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.

作者信息

Piao Chunli, Zhang Qi, Jin De, Wang Li, Tang Cheng, Zhang Naiwen, Lian Fengmei, Tong Xiaolin

机构信息

Shenzhen Hospital, Guangzhou University of Chinese Medicine (Futian), Shenzhen 518000, Guangdong, China.

Changchun University of Chinese Medicine, Changchun 130000, Jilin, China.

出版信息

Evid Based Complement Alternat Med. 2020 Oct 31;2020:6754761. doi: 10.1155/2020/6754761. eCollection 2020.

Abstract

Diabetic nephropathy (DN) is one of the most common complications of diabetes mellitus. Owing to its complicated pathogenesis, no satisfactory treatment strategies for DN are available. Milkvetch Root is a common traditional Chinese medicine (TCM) and has been extensively used to treat DN in clinical practice in China for many years. However, due to the complexity of botanical ingredients, the exact pharmacological mechanism of Milkvetch Root in treating DN has not been completely elucidated. The aim of this study was to explore the active components and potential mechanism of Milkvetch Root by using a systems pharmacology approach. First, the components and targets of Milkvetch Root were analyzed by using the Traditional Chinese Medicine Systems Pharmacology database. We found the common targets of Milkvetch Root and DN constructed a protein-protein interaction (PPI) network using STRING and screened the key targets via topological analysis. Enrichment of Gene Ontology (GO) pathways and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were analyzed. Subsequently, major hubs were identified and imported to the Database for Annotation, Visualization and Integrated Discovery for pathway enrichment analysis. The binding activity and targets of the active components of Milkvetch Root were verified by using the molecular docking software SYBYL. Finally, we found 20 active components in Milkvetch Root. Moreover, the enrichment analysis of GO and KEGG pathways suggested that AGE-RAGE signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, and TNF signaling pathway might be the key pathways for the treatment of DN; more importantly, 10 putative targets of Milkvetch Root (AKT1, VEGFA, IL-6, PPARG, CCL2, NOS3, SERPINE1, CRP, ICAM1, and SLC2A) were identified to be of great significance in regulating these biological processes and pathways. This study provides an important scientific basis for further elucidating the mechanism of Milkvetch Root in treating DN.

摘要

糖尿病肾病(DN)是糖尿病最常见的并发症之一。由于其发病机制复杂,目前尚无令人满意的DN治疗策略。黄芪是一种常见的传统中药,多年来在中国临床实践中已被广泛用于治疗DN。然而,由于植物成分的复杂性,黄芪治疗DN的确切药理机制尚未完全阐明。本研究旨在采用系统药理学方法探讨黄芪的活性成分和潜在机制。首先,利用中药系统药理学数据库分析黄芪的成分和靶点。我们找到了黄芪和DN的共同靶点,使用STRING构建了蛋白质-蛋白质相互作用(PPI)网络,并通过拓扑分析筛选出关键靶点。分析了基因本体论(GO)通路和京都基因与基因组百科全书(KEGG)通路的富集情况。随后,确定了主要枢纽,并导入注释、可视化和综合发现数据库进行通路富集分析。使用分子对接软件SYBYL验证了黄芪活性成分的结合活性和靶点。最后,我们在黄芪中发现了20种活性成分。此外,GO和KEGG通路的富集分析表明,晚期糖基化终产物-受体(AGE-RAGE)信号通路、缺氧诱导因子-1(HIF-1)信号通路、磷脂酰肌醇-3激酶-蛋白激酶B(PI3K-Akt)信号通路和肿瘤坏死因子(TNF)信号通路可能是治疗DN的关键通路;更重要的是,确定了黄芪的10个假定靶点(AKT1、血管内皮生长因子A(VEGFA)、白细胞介素-6(IL-6)、过氧化物酶体增殖物激活受体γ(PPARG)、趋化因子配体2(CCL2)、一氧化氮合酶3(NOS3)、丝氨酸蛋白酶抑制剂E1(SERPINE1)、C反应蛋白(CRP)、细胞间黏附分子1(ICAM1)和溶质载体家族2成员1(SLC2A))在调节这些生物学过程和通路中具有重要意义。本研究为进一步阐明黄芪治疗DN的机制提供了重要的科学依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03de/7648691/4591775c3010/ECAM2020-6754761.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验